N-Methyltryptamine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description

Template:Short description <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = N-Methyltryptamine | INN = | _drugtype =

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=11142CNCCc1c[nH]c2ccccc121S/C11H14N2/c1-12-7-6-9-8-13-11-5-3-2-4-10(9)11/h2-5,8,12-13H,6-7H2,1H3NCIKQJBVUNUXLW-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite8789 | _combo_data= | _physiological_data= | _clinical_data=

| _legal_data=Schedule I (isomer of AMT)

| _other_data=2-(1H-Indol-3-yl)-N-methylethan-1-amine

| _image_0_or_2 = NMT structure.svg | _image_LR =

| _datapage = N-Methyltryptamine (data page) | _vaccine_target=_type_not_vaccine | _legal_all=Schedule I (isomer of AMT) | _ATC_prefix_supplemental= | _has_EMA_link = | CAS_number=61-49-4 | PubChem=6088 | ChemSpiderID=5863 | ChEBI=28136 | ChEMBL=348588 | DrugBank= | KEGG=C06213 | _hasInChI_or_Key=yes | UNII=6FRL4L3Z7V | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields=verified |Watchedfields=verified |verifiedrevid=464372446}}

N-Methyltryptamine (NMT), also known as monomethyltryptamine, is a chemical compound of the tryptamine family and a naturally occurring compound found in the human body and certain plants.

It is biosynthesized in humans from tryptamine by certain N-methyltransferase enzymes, such as indolethylamine N-methyltransferase.[1][2] It is a known component in human urine.[3] NMT is an alkaloid derived from L-tryptophan that has been found in the bark, shoots and leaves of several plant genera, including Virola, Acacia, Mimosa, and Desmanthus—often together with the related compounds N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).[4]

NMT acts as a serotonin receptor agonist and serotonin releasing agent[5] and is said to produce hallucinogenic effects in humans.[6][7][8]

Effects

Orally administered NMT appears to produce no psychoactive effects, likely as a result of extensive first-pass metabolism.[9]

Per Roger W. Brimblecombe and colleagues, NMT is inactive in humans, with few details provided.[10] On the other hand, according to Alexander Shulgin and others, NMT is active via non-oral routes.[6][7][8] It has been said to produce psychedelic effects at doses of 50 to 120Script error: No such module "String".mg by smoking or vaporization, with a duration of seconds to minutes.[6][7][8] Based on preliminary reports, NMT is reported to produce visuals, but its effects are described as primarily spatial in nature, among other effects.[6][7][8]

NMT has also been reported to be orally active in combination with a monoamine oxidase inhibitor (MAOI).[7][8]

Pharmacology

NMT is known to act as a potent serotonin 5-HT2A receptor full agonist (EC50Tooltip half-maximal effective concentration = 50.7Script error: No such module "String".nM; EmaxTooltip maximal efficacy = 96%).[5] It has been reported to be inactive in activating the β-arrestin pathway of the receptor and hence appears to be a biased agonist of the serotonin 5-HT2A receptor.[5] In contrast to the serotonin 5-HT2A receptor, the drug is not an agonist of the serotonin 5-HT1A receptor.[5]

In addition to its serotonin 5-HT2A receptor agonism, NMT is a potent serotonin releasing agent (EC50 = 22.4Script error: No such module "String".nM).[5] It also releases dopamine and norepinephrine much more weakly (EC50 = 321Script error: No such module "String".nM and 733Script error: No such module "String".nM, respectively; 14- and 33-fold less than for serotonin, respectively).[5]

Society and culture

Legal status

In the United States NMT is considered a schedule 1 controlled substance as an positional isomer of Alpha-methyltryptamine (AMT).[11]

See also

References

<templatestyles src="Reflist/styles.css" />

  1. Script error: No such module "Citation/CS1".
  2. Script error: No such module "Citation/CS1".
  3. Script error: No such module "Citation/CS1".
  4. Script error: No such module "citation/CS1".
  5. a b c d e f Script error: No such module "Citation/CS1".
  6. a b c d Script error: No such module "citation/CS1".
  7. a b c d e Script error: No such module "citation/CS1".
  8. a b c d e Script error: No such module "citation/CS1".
  9. Script error: No such module "citation/CS1".
  10. Script error: No such module "citation/CS1".
  11. Script error: No such module "citation/CS1".

Script error: No such module "Check for unknown parameters".

External links

Template:Neurotransmitters Template:Psychedelics Template:Serotonin receptor modulators Template:Monoamine releasing agents Script error: No such module "Navbox".